QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mardon, J. Articles by Coxam, V. Search for Related Content PubMed PubMed Citation Articles by Mardon, J. Articles by Coxam, V.

---

Nutrient Physiology, Metabolism, and Nutrient-Nutrient Interactions

Long-Term Intake of a High-Protein Diet with or without Potassium Citrate Modulates Acid-Base Metabolism, but Not Bone Status, in Male Rats¹

Unité de Nutrition Humaine UMR1019, INRA Clermont-Ferrand/Theix, 63122 Saint Genès Champanelle, France

^* To whom correspondence should be addressed. E-mail: jmardon{at}clermont.inra.fr.

	ABSTRACT

TOP ABSTRACT Introduction Materials and Methods Results Discussion LITERATURE CITED

 
High dietary protein intake generates endogenous acid production, which may adversely affect bone health. Alkaline potassium citrate (Kcit)² may contribute to the neutralization of the protein-induced metabolic acidosis. We investigated the impact of 2 levels of protein intake and Kcit supplementation on acid-base metabolism and bone status in rats. Two-month-old Wistar male rats were randomly assigned to 4 groups (n = 30 per group). Two groups received a normal-protein content (13%) (NP) or a high-protein (HP) content diet (26%) for 19 mo. The 2 other groups received identical diets supplemented with Kcit (3.60%) (NPKcit and HPKcit). Rats were pair-fed based on the ad libitum intake of the HP group. At 9, 16, and 21 mo of age, 10 rats of each group were killed. The HP diet induced a metabolic acidosis characterized by hypercalciuria, hypermagnesuria, and hypocitraturia at all ages. Kcit supplementation neutralized this effect, as evidenced by decreased urinary calcium and magnesium excretion by the HPKcit rats. Femoral bone mineral density, biomechanical properties, bone metabolism biomarkers (osteocalcin and deoxypyridinoline), and plasma insulin-like growth factor 1 levels were not affected by the different diets. Nevertheless, at 21 mo of age, calcium retention was reduced in the HP group. This study suggests that lifelong excess of dietary protein results in low-grade metabolic acidosis without affecting the skeleton, which may be protected by an adequate calcium supply.

	Introduction

TOP ABSTRACT Introduction Materials and Methods Results Discussion LITERATURE CITED

In particular, an imbalanced protein-potassium ratio results in low-grade metabolic acidosis (2). Protein-rich diets are considered acidogenic due to the excess of sulphuric anions produced by the catabolism of sulfur amino acids. Moreover, low fruit and vegetable intake decreases dietary minerals and organic anions, including potassium citrate (Kcit) and malate. Thus, the availability of alkaline organic salts potentially is insufficient to neutralize the endogenous acid production associated with excessive protein intake.

To counteract the excess dietary acid load, the homeostatic systems excrete increased amounts of urinary calcium and phosphorus (3,4). Hypercalciuria can have multiple pathological consequences (5), including nephrolithiasis, and it may contribute to the pathogenesis of osteoporosis. Acidosis promotes continual release of alkaline calcium salts from the skeleton to maintain the acid-base balance (6,7) and this may result in bone loss in the long term. Indeed, metabolic acidosis is associated with lower bone mineral density (BMD) in women (8) and rats (9). In an in vitro model for metabolic acidosis, significant bone calcium efflux was observed (10) and cell function was impaired, as evidenced by stimulation of osteoclastic bone resorption and inhibition of osteoblastic formation (11,12).

Similarly, high-protein (HP) intake and the associated acidosis are considered potentially detrimental for bone health in humans (13,14) and rats (15). However, in contrast to the well-characterized effects of dietary protein on urinary calcium excretion, the effect on bone status needs further insight. Actually, the impact of dietary protein on bone remains somewhat controversial, because several reports have emphasized that HP intake benefits bone health (16–18). Indeed, protein intake may favorably influence bone metabolism by stimulating the anabolic action of insulin-like growth factor 1 (IGF-1) on bone (19).

Fruit and vegetable intake provides potassium salts, especially Kcit. Previous investigations have reported beneficial effects of dietary potassium and potassium-rich foods (fruits and vegetables) on bone health (20–23). Given that a HP diet could induce osteopenia, it has been hypothesized that Kcit intake would neutralize the diet-induced metabolic acidosis and may be associated with a higher bone mass (24).

Thus, long-term investigations are needed to completely define the role of HP intake and acid-base balance in age-related bone loss. The goal of this study was to carefully identify the long-term effects of protein content in the diet on bone status and to test if alkaline-forming supplements had favorable effects on bone health. Using rats as a model, the study was designed to address 2 specific questions: 1) does a long-term HP diet (26%) have beneficial or detrimental effects on bone status when compared with a normal-protein diet (NP) (13%); and 2) does Kcit supplementation modulate the bone response to dietary protein intake.

	Materials and Methods

TOP ABSTRACT Introduction Materials and Methods Results Discussion LITERATURE CITED

 
Animals and experimental design

The study was conducted in accordance with the regional Ethics Committee for animal experiments in France. A total of 120 male Wistar rats (2 mo old, mean weight 316 g) were purchased from Institut National de la Recherche Agronomique. The rats were housed individually in plastic cages at 25°C, in 12-h-light/12-h-dark cycles and had free access to water. We measured body weight and food intake weekly. Male rats were chosen to eliminate the potential confounding effect of hormonal fluctuations.

At the beginning of the study, the rats were randomly assigned to 4 groups (n = 30). Two groups received diets containing either NP content [13% (g/100 g)] or HP content (26%). The other 2 groups received identical diets supplemented with Kcit (3.60%) (NPKcit and HPKcit) (Table 1). All diets were purchased from Institut National de la Recherche Agronomique. All rats were fed a measured amount of diet, corresponding to 90–95% of the mean ad libitum intake of the HP groups, which had the lowest food intake. The pair-feeding protocol allowed us to match the energy intakes of the groups, providing healthy, nonobese control rats for the study (25). All diets contained the same amount of lipid, fiber, vitamins, and minerals, except potassium (0.36 vs. 1.66% in supplemented groups). Thus, all rats consumed similar amounts of dietary calcium (0.25%) and phosphorus (0.20%) (Ca:P ratio = 1.25).

Biochemical analyses

    Minerals. Urine samples were appropriately diluted in lanthanum oxide solution. Urinary calcium and magnesium concentrations were determined by atomic absorption spectrophotometry (AA800, Perkin Elmer). Sodium and potassium concentrations were measured by atomic emission spectrophotometry. A total of 200 mg of dried samples (food and feces) was dried-ashed (10 h at 500°C) and extracted until discoloration at 130°C in HNO₃-H₂O₂ (2:1) (Suprapur; Merck). For calcium determination by atomic absorption spectroscopy, the final dilution was performed with lanthanum oxide. We calculated calcium retention (µmol/24 h), defined as [calcium intake – (urinary calcium excretion + fecal calcium excretion)].

    Organic anions. Urine was diluted 400-fold with milli-Q water. Chloride, phosphate, sulfate, and citrate concentrations were determined by ionic chromatography (DX320, Dionex). The anions were separated on a 4- x 250-mm AS 11 column/AG 11 precolumn (flow rate 1 mL/min). An EG40 eluent generator controlled the elution using an OH^– gradient (0.5–35 mmol/L in 20 min) and the conductimetry detector was preceded by an automated storage and retrieval system self-regenerating suppressor.

    IGF-1. Serum IGF-1 concentrations were measured using a 2-site immunoenzymometric assay (OCTEIA rat/mouse IGF-1 kit, IDS). The sensitivity of the assay was 82 µg/L. Intra- and interassay variations were 5.7 and 10.7%, respectively.

    Parathyroid hormone. Plasma parathyroid hormone (PTH) concentrations were determined using an immunoradiometric assay kit (Immunotopics). The sensitivity was 1.0 ng/L. The intra- and interassay variations were 4.1 and 4.5%, respectively.

    Bone biomarkers. Plasma osteocalcin (OC) concentrations were measured by an immunoradiometric assay (Immunotopics). The sensitivity was 0.01 µg/L. The intra- and interassay variations were 2.0 and 4.5%, respectively. The urinary deoxypyridinoline (DPD) concentration (nmol/L) was determined using a radioimmunoassay (Pyrilinks-D RIA kit, Metra Biosystems). The sensitivity was 2 nmol/L. The intra- and interassay variations were 4 and 6%, respectively. DPD excretion rates (nmol/24 h) were calculated using the prior 24-h urine volumes.

Physical measurements

    BMD. BMD was assessed by dual-energy X-ray absorptiometry using a Hologic QDR-4500 A X-ray bone densitometer (Hologic). Total femoral BMD (T-BMD), metaphyseal BMD (M-BMD), and diaphyseal BMD (D-BMD) were determined. For M-BMD and D-BMD measurements, scans were cut and analyzed as follows: the first cut of the femur was performed at the upper quarter and the next cut at the lower quarter. D-BMD corresponded to the density of the 2nd and 3rd quarters of the femur. M-BMD was calculated as the mean of the upper and lower quarters of the femur (26).

    Mechanical testing of femurs. Femoral length and mean diaphyseal diameter were measured with a precision caliper (Mitutoyo). Because of the irregular shape of the femoral diaphysis, the femoral diameter used in the calculation was the mean of the greatest and smallest femoral diaphyseal diameters. The femoral failure load was determined using a 3-point bending test (27) with a Universal Testing Machine (Instron 4501, Instron). The 2 lower supports were separated by a 20-mm distance and an upper crosshead roller (6-mm diameter) was applied in front of the middle of the bone at a speed of 0.5 mm/min until failure to guarantee that 85–90% of the bone flexure was due to bending. Load (Newtons) at rupture was recorded.

Statistical analyses

Results are expressed as means ± SEM and were analyzed with XLSTAT (Addinsoft). The sample size was based on a previous study, which used 7 rats per group, of the effect of protein intake on BMD in 8-mo-old male rats (28) followed during 7 mo. Given the duration of the present study, we used 10 rats per group. The normality of the data were verified. All variables were subjected to a 3-way ANOVA, testing for any difference among the groups. Thus, the main effects assessed were protein intake (NP/HP), Kcit supplementation, age (9, 16, and 21 mo), and their interactions. When an effect was significant (P < 0.05), we used the Student-Newman-Keuls multiple comparison test to determine specific differences between means. Linear regressions were performed to study internal correlations among variables and the Pearson test was carried out to assess their significance.

	Results

TOP ABSTRACT Introduction Materials and Methods Results Discussion LITERATURE CITED

 
    Body weight and dietary intake. The body weight of all rats increased between 9 and 16 mo of age (P = 0.01) (Table 2). Body weight tended to decrease between 16 and 21 mo (P = 0.07). Body weights did not differ among the 4 groups. Due to the pair-feeding, the feed intakes did not differ and were 22.1 ± 0.9 g at 9 mo old, 22.4 ± 1.2 g at 16 mo old, and 21.0 ± 1.3 g at 21 mo old.

    Urinary anion excretion. As expected, rats fed Kcit excreted larger amounts of citrate in the urine (12- to 16-fold more) than those that where not supplemented (P < 0.0001) (Fig. 1A). At 9, 16, and 21 mo of age, citrate excretion was modulated by the protein level in the diet (P < 0.0001); it was lower in the HP group than in the NP group and, at 9 mo, it was lower in the HPKcit group than in the NPKcit group. Similar trends were observed at 16 and 21 mo of age (P = 0.021). Urinary phosphate (Fig. 1B) and sulfate (Fig. 1C) excretion increased in the groups fed the HP and HPKcit diets (P < 0.0001) compared with those fed the NP and NPKcit diets. At 21 mo, both phosphate and sulfate excretions were lower in the HP group than in the HPKcit group (P = 0.001). Chloride excretion did not vary between the groups (data not shown).

View larger version (31K): [in this window] [in a new window]   FIGURE 1  Effect of protein intake and Kcit supplementation on urinary citrate (A), phosphate (B), and sulfate (C) excretion (mmol/24 h) at 9, 16, and 21 mo of age. Values are means ± SEM, n = 10. *Different from 9 and 16 mo of age, P 0.05. a–d,Difference between NP, HP, NPKcit, and HPKcit groups at a given age. Means without a common letter differ, P 0.05.

View larger version (34K): [in this window] [in a new window]   FIGURE 2  Effect of protein intake and Kcit supplementation on T- BMD (A), femoral biomechanical resistance (B), plasma OC (C), and the urinary DPD excretion rate (D) at 9, 16, and 21 mo of age. Values are means ± SEM, n = 10. *Different from 9 and 16 mo of age, P 0.05. Different from 9 mo of age, P 0.05.

    Bone biomarkers. Plasma OC was reduced in all groups at 16 and 21 mo (P < 0.0001) compared with 9 mo (Fig. 2C). The urinary DPD excretion rate was similar at 9 and 16 mo of age then decreased at 21 mo (P < 0.0001) (Fig. 2D). Both bone biomarkers were unaffected by diet protein content and Kcit supplementation. OC was positively correlated with calcium retention (r = 0.660; P = 0.014).

    Plasma IGF-1. Plasma IGF-1 concentrations were lower after 21 mo (P < 0.0001) compared with 9- and 16-mo-old rats (data not shown). The groups did not differ at any age.

    Plasma PTH. Plasma PTH concentrations increased at 16 and 21 mo (P = 0.001) compared with 9 mo of age. The 4 groups (data not shown) did not differ at any age.

	Discussion

TOP ABSTRACT Introduction Materials and Methods Results Discussion LITERATURE CITED

 
A relatively high dietary protein intake can generate a substantial fixed acidity, which inconsistently has been reported to adversely affect bone health (13–15). Kcit could possibly be used to neutralize this acid load. We investigated the effect of 2 levels of dietary protein (13 or 26%) in the presence or absence of Kcit supplementation on acid-base metabolism and bone status. We used male Wistar rats as an experimental model for age-related bone loss (29) and monitored them until 21 mo of age.

    Characterization of HP diet-induced low-grade metabolic acidosis. The HP diet elicited an acid load, which was characterized by decreased urine pH compared with the NP diet group at all ages (Table 2). The HP diet was associated with significant calciuria (Table 3). Hypercalciuria is correlated with net acid excretion (30) and is a well-known consequence of HP diet ingestion (31,32). In the kidney, it has been attributed to an increased glomerular filtration rate and a decreased tubular calcium reabsorption, which neutralizes SO₄^2– generated by catabolism of sulfur amino acids (4). The changes in magnesium excretion were similar (30% increase between the NP and HP groups). This trend is consistent with previous short-term studies and suggests that magnesium, in addition to calcium, compensates for metabolic acidosis in the long term (33). Increased urinary sulfate and phosphate excretion was observed with the HP diet (Fig. 1). The increased sulfate elimination resulted from a greater sulfur amino acid intake (34). The higher phosphate excretion rate could be due to the presence of more organic phosphorus in the HP diet (35), but impaired tubular reabsorption of phosphate (15) is another possibility. Hypocitraturia was another major factor associated with dietary protein excess (Fig. 1A) (36). This is consistent with reports of renal acidosis resulting in decreased proximal tubular reabsorption of citrate and impaired citrate transport (37,38).

    Kcit supplementation affected acid-base metabolism. In contrast to western diets, the NPKcit and HPKcit diets provided a relative excess of organic anions (Kcit: 35.95 g/kg) compared with sulfur amino acids (6.9 g/kg in NP diets and 13.8 g/kg in HP diets). The protein:potassium ratio is a reliable predictor of diet net acid load and these 2 diets were previously shown to prevent metabolic acidosis (2).

Indeed, Kcit supplementation significantly increased urine pH, consistent with previous work (22,39). The administration of Kcit resulted in increased urinary potassium (Table 2) and citrate excretion (Fig. 1) in both the NPKcit and HPKcit groups. However, the HP diet limited the effect of the Kcit supplementation on citraturia. The Kcit neutralizing effect was further confirmed by lower urinary calcium and magnesium excretion (Tables 2, 3). The Kcit probably exerted its effects by neutralizing endogenous acidity by KHCO₃^– generation, glutamine sparing (40,41), and modulation of hepatic urea synthesis for removal of bicarbonate (42). Furthermore, potassium influences the expression of the proximal tubular Na/sulfate-cotransporter. Although Kcit supplementation may have restored SO₄^2– reabsorption through a reversal of transporter downregulation by acidosis, it increased sulfate excretion (Fig. 1C). This was consistent with data from Sabboh et al. (35), who suggested that sulfate reabsorption could not match increased generation of SO₄^2–. Moreover, it seems the capacity of the kidney to excrete sulfate and phosphate was maintained during aging with Kcit supplementation, whereas it was altered after 21 mo in the NP and HP rats.

    HP diet and Kcit supplementation did not affect bone quality. The sole change reported on bone status was a marked age-related bone loss at the end of the experimental period (21 mo of age) (Fig. 2). Bone density changes were consistent with the observed biomarker variations and resulted in decreased bone strength (Fig. 2B). These alterations may be related to the decreased IGF-1, a bone anabolic hormone, secretion. The lower plasma IGF-1 levels probably result in age-induced perturbation of the hypothalamo-adenohypophysial-somatotrophic axis (43,44). Secondary hyperparathyroidism has been reported in old rats and was suggested to contribute to bone alteration. In parallel, these changes were associated with the impaired ability of the kidney to excrete the dietary acid load with aging and were characterized by acidification of excreted urine and increased loss of urinary magnesium and calcium.

The femoral BMD was not affected by protein intake or Kcit supplementation (Fig. 2A). Indeed, the groups did not differ at any of the time points. Corresponding femoral biomechanical properties remained unchanged as well (Fig. 2B). These results are consistent with previous observations in rats by Whiting and Draper (45), Calvo et al. (46), and Goulding and Campbell (47), showing no change in femoral bone mass or macromineral composition in response to dietary protein excess (30, 35, and 60% excess, respectively) despite hypercalciuria. In contrast, using histomorphometric analysis, Amanzadeh et al. (15) observed bone loss in rats fed a 48% casein diet during 59 d and displaying hypercalciuria and hypocitraturia.

The physical bone measurements were consistent with the bone biomarker levels, which did not vary between the 4 groups (Fig. 2C,D). Yet metabolic acidosis has been demonstrated to stimulate osteoclastic resorption and inhibit osteoblastic collagen synthesis in vitro (12,48). As far as hydroxyproline can be considered as a relevant indicator of bone resorption, HP intake was associated with increased resorption levels (32,47,49). However, Creedon and Cashman (50) and Shapses et al. (51) reported no effect of HP diets on urinary excretion of collagen pyridinium crosslinks in rats and human subjects. In this study, the absence of variation in bone metabolism can be attributed to stable circulating PTH, a potent stimulator of bone resorption, levels.

Thus, the bone variables in this study lead us to conclude that long-term, low-grade metabolic acidosis, induced by a slightly hyperproteic diet (26% casein), does not affect the skeleton. However, it would be interesting to repeat the analysis with female rats that are subject to greater hormonal variations. Actually, it appears that the effects of dietary protein on bone status depend on multiple, interacting variables (52), including additional dietary factors. Protein and calcium, in particular, seem to act synergistically on human bone (53,54). An adequate calcium supply, as in this study, may reduce or offset the negative effects of protein on bone mass. Here, calcium retention was not significantly affected by the HP (26%) diet or citrate salt intake at 9 and 16 mo of age (Table 3), although calcium fecal excretion increased. Nevertheless, calcium retention was altered in the HP rats compared with the NP rats after 21 mo. This was a result of both higher fecal and urinary calcium excretion. Calcium retention did not vary between the NPKcit and the HPKcit groups. In summary, in the older rats, the HP diet had deleterious effects on calcium retention and Kcit supplementation could prevent this impairment. The impact of HP intake on calcium retention is controversial, because Creedon and Kashman (50) found no effect of this parameter in growing rats. Femoral BMD was unchanged in this study at 21 mo, but it is conceivable that bone density would be altered at later time points. These results remain to be confirmed in humans, given the differences suspected in intestinal calcium absorption.

The role of dietary protein in bone health is currently debated. Some authors argue that HP diets diminish bone health (13,55), whereas others speculate that it is favorable for the skeleton (17,56). Considering that dietary protein supplies the amino acid building blocks for the bone matrix and stimulates the IGF-1 system, it may have a magnitude-dependent anabolic effect on bone. The plasma IGF-1 levels in this study did not differ between the 4 groups. However, IGF-1 is an osteotrophic factor and it was previously shown to be regulated by nutritional status, especially dietary protein intake (44). Inappropriate protein intake (2.5% casein diet) impairs the IGF-1 system and has been suggested to lead to decreased bone mineral mass and fragility in rats (57). The absence of variation in IGF-1 levels in this study is consistent with the BMD values and probably reflects that our diets were less restrictive, particularly with respect to protein content.

In conclusion, the HP diet induced a low-grade metabolic acidosis, which persisted over the entire duration of the experiment. Kcit supplementation had alkalinizing effects and neutralized the increased acid load. Neither beneficial nor detrimental effects associated with HP intake or Kcit supplementation was reported on bone status or metabolism under our experimental conditions. This could be explained by an adequate calcium supply, because calcium intake may offset the effects of a protein-generated acid load on bone mass.

	FOOTNOTES

 
¹ Author disclosures: J. Mardon, V. Habauzit, A. Trzeciakiewicz, M.-J. Davicco, P. Lebecque, S. Mercier, J.-C. Tressol, M.-N. Horcajada, C. Demigné, and V. Coxam, no conflicts of interest.

² Abbreviations used: BMD, bone mineral density; D-BMD, diaphyseal bone mineral density; DPD, deoxypyridinoline; HP, high-protein; HPKcit, high-protein diet supplemented with potassium citrate; IGF-1, insulin-like growth factor 1; Kcit, potassium citrate; M-BMD, metaphyseal bone mineral density; NP, normal protein; NPKcit, normal protein diet supplemented with potassium citrate; OC, osteocalcin; PTH, parathyroid hormone; T-BMD, total bone mineral density.

Manuscript received 10 September 2007. Initial review completed 3 October 2007. Revision accepted 29 January 2008.

	LITERATURE CITED

TOP ABSTRACT Introduction Materials and Methods Results Discussion LITERATURE CITED

 

1. Eaton SB, Eaton SB III. Paleolithic vs. modern diets: selected pathophysiological implications. Eur J Nutr. 2000;39:67–70.[CrossRef][Medline]

2. Frassetto LA, Todd KM, Morris RC Jr, Sebastian A. Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. Am J Clin Nutr. 1998;68:576–83.[Abstract]

3. Lemann J Jr, Gray RW, Maierhofer WJ, Cheung HS. The importance of renal net acid excretion as a determinant of fasting urinary calcium excretion. Kidney Int. 1986;29:743–6.[Medline]

4. Alpern RJ, Sakhaee K. The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis. 1997;29:291–302.[Medline]

5. Mitch WE. Metabolic and clinical consequences of metabolic acidosis. J Nephrol. 2006;19 Suppl 9:S70–5.[Medline]

6. Green J, Kleeman CR. The role of bone in the regulation of systemic acid-base balance. Contrib Nephrol. 1991;91:61–76.[Medline]

7. Barzel US. The skeleton as an ion exchange system: implications for the role of acid-base imbalance in the genesis of osteoporosis. J Bone Miner Res. 1995;10:1431–6.[Medline]

8. New SA, MacDonald HM, Campbell MK, Martin JC, Garton MJ, Robins SP, Reid DM. Lower estimates of net endogenous non-carbonic acid production are positively associated with indexes of bone health in premenopausal and perimenopausal women. Am J Clin Nutr. 2004;79:131–8.[Abstract/Free Full Text]

9. Won JH, Fukuda S, Sato R, Naito Y. Bone histomorphometric changes due to differences in calcium intake under metabolic acidosis in rats. J Vet Med Sci. 1996;58:611–6.[Medline]

10. Bushinsky DA. Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis. Am J Physiol. 1989;256:F836–42.[Medline]

11. Arnett T. Acid-base regulation of bone metabolism. Int Congr Ser. 2007;1297:255–67.[CrossRef]

12. Krieger NS, Sessler NE, Bushinsky DA. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol. 1992;262:F442–8.[Medline]

13. Feskanich D, Willett WC, Stampfer MJ, Colditz GA. Protein consumption and bone fractures in women. Am J Epidemiol. 1996;143:472–9.[Abstract/Free Full Text]

14. Zwart SR, Davis-Street JE, Paddon-Jones D, Ferrando AA, Wolfe RR, Smith SM. Amino acid supplementation alters bone metabolism during simulated weightlessness. J Appl Physiol. 2005;99:134–40.[Abstract/Free Full Text]

15. Amanzadeh J, Gitomer WL, Zerwekh JE, Preisig PA, Moe OW, Pak CY, Levi M. Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int. 2003;64:2142–9.[CrossRef][Medline]

16. Promislow JH, Goodman-Gruen D, Slymen DJ, Barrett-Connor E. Protein consumption and bone mineral density in the elderly: the Rancho Bernardo Study. Am J Epidemiol. 2002;155:636–44.[Abstract/Free Full Text]

17. Kerstetter JE, O'Brien KO, Caseria DM, Wall DE, Insogna KL. The impact of dietary protein on calcium absorption and kinetic measures of bone turnover in women. J Clin Endocrinol Metab. 2005;90:26–31.[Abstract/Free Full Text]

18. Dawson-Hughes B, Harris SS, Rasmussen H, Song L, Dallal GE. Effect of dietary protein supplements on calcium excretion in healthy older men and women. J Clin Endocrinol Metab. 2004;89:1169–73.[Abstract/Free Full Text]

19. Rizzoli R, Bonjour JP. Dietary protein and bone health. J Bone Miner Res. 2004;19:527–31.[CrossRef][Medline]

20. New SA, Robins SP, Campbell MK, Martin JC, Garton MJ, Bolton-Smith C, Grubb DA, Lee SJ, Reid DM. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr. 2000;71:142–51.[Abstract/Free Full Text]

21. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999;69:727–36.[Abstract/Free Full Text]

22. Marangella M, Di Stefano M, Casalis S, Berutti S, D'Amelio P, Isaia GC. Effects of potassium citrate supplementation on bone metabolism. Calcif Tissue Int. 2004;74:330–5.[CrossRef][Medline]

23. Sellmeyer DE, Schloetter M, Sebastian A. Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab. 2002;87:2008–12.[Abstract/Free Full Text]

24. Macdonald HM, New SA, Fraser WD, Campbell MK, Reid DM. Low dietary potassium intakes and high dietary estimates of net endogenous acid production are associated with low bone mineral density in premenopausal women and increased markers of bone resorption in postmenopausal women. Am J Clin Nutr. 2005;81:923–33.[Abstract/Free Full Text]

25. Pugh TD, Klopp RG, Weindruch R. Controlling caloric consumption: protocols for rodents and rhesus monkeys. Neurobiol Aging. 1999;20:157–65.[CrossRef][Medline]

26. Omi N, Ezawa I. The effect of ovariectomy on bone metabolism in rats. Bone. 1995;17:S163–8.[Medline]

27. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone. 1993;14:595–608.[Medline]

28. Bourrin S, Toromanoff A, Ammann P, Bonjour JP, Rizzoli R. Dietary protein deficiency induces osteoporosis in aged male rats. J Bone Miner Res. 2000;15:1555–63.[CrossRef][Medline]

29. Schapira D, Lotan-Miller R, Barzilai D, Silbermann M. The rat as a model for studies of the aging skeleton. Cells Mater. 1991; Suppl 1:181–8.

30. Lemann J Jr. Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron. 1999;81 Suppl 1:18–25.[Medline]

31. Allen LH, Hall TE. Calcium metabolism, intestinal calcium-binding protein, and bone growth of rats fed high protein diets. J Nutr. 1978;108:967–72.[Abstract/Free Full Text]

32. Chan EL, Swaminathan R. The effect of high protein and high salt intake for 4 months on calcium and hydroxyproline excretion in normal and oophorectomized rats. J Lab Clin Med. 1994;124:37–41.[Medline]

33. Sabboh H, Horcajada MN, Coxam V, Tressol JC, Besson C, Remesy C, Demigne C. Effect of potassium salts in rats adapted to an acidogenic high-sulfur amino acid diet. Br J Nutr. 2005;94:192–7.[Medline]

34. Nakamura H, Kajikawa R, Ubuka T. A study on the estimation of sulfur-containing amino acid metabolism by the determination of urinary sulfate and taurine. Amino Acids. 2002;23:427–31.[CrossRef][Medline]

35. Sabboh H, Coxam V, Horcajada MN, Remesy C, Demigne C. Effects of plant food potassium salts (citrate, galacturonate or tartrate) on acid-base status and digestive fermentations in rats. Br J Nutr. 2007;98:72–7.[Medline]

36. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66:140–6.[Abstract/Free Full Text]

37. Brennan TS, Klahr S, Hamm LL. Citrate transport in rabbit nephron. Am J Physiol. 1986;251:F683–9.[Medline]

38. Labow BI, Souba WW, Abcouwer SF. Mechanisms governing the expression of the enzymes of glutamine metabolism–glutaminase and glutamine synthetase. J Nutr. 2001;131:S2467–74.[Abstract/Free Full Text]

39. He FJ, MacGregor GA. Fortnightly review: beneficial effects of potassium. BMJ. 2001;323:497–501.[Free Full Text]

40. Demigne C, Sabboh H, Remesy C, Meneton P. Protective effects of high dietary potassium: nutritional and metabolic aspects. J Nutr. 2004;134:2903–6.[Abstract/Free Full Text]

41. Remer T, Manz F. Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc. 1995;95:791–7.[CrossRef][Medline]

42. Haussinger D. Liver regulation of acid-base balance. Miner Electrolyte Metab. 1997;23:249–52.[Medline]

43. Sonntag WE, Lenham JE, Ingram RL. Effects of aging and dietary restriction on tissue protein synthesis: relationship to plasma insulin-like growth factor-1. J Gerontol. 1992;47:B159–63.

44. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994;15:80–101.[Abstract/Free Full Text]

45. Whiting SJ, Draper HH. Effect of chronic high protein feeding on bone composition in the adult rat. J Nutr. 1981;111:178–83.[Abstract/Free Full Text]

46. Calvo MS, Bell RR, Forbes RM. Effect of protein-induced calciuria on calcium metabolism and bone status in adult rats. J Nutr. 1982;112:1401–13.[Abstract/Free Full Text]

47. Goulding A, Campbell DR. Effects of oral loads of sodium chloride on bone composition in growing rats consuming ample dietary calcium. Miner Electrolyte Metab. 1984;10:58–62.[Medline]

48. Arnett T. Regulation of bone cell function by acid-base balance. Proc Nutr Soc. 2003;62:511–20.[CrossRef][Medline]

49. Schuette SA, Hegsted M, Zemel MB, Linkswiler HM. Renal acid, urinary cyclic AMP, and hydroxyproline excretion as affected by level of protein, sulfur amino acid, and phosphorus intake. J Nutr. 1981;111:2106–16.[Abstract/Free Full Text]

50. Creedon A, Cashman KD. The effect of high salt and high protein intake on calcium metabolism, bone composition and bone resorption in the rat. Br J Nutr. 2000;84:49–56.[Medline]

51. Shapses SA, Robins SP, Schwartz EI, Chowdhury H. Short-term changes in calcium but not protein intake alter the rate of bone resorption in healthy subjects as assessed by urinary pyridinium cross-link excretion. J Nutr. 1995;125:2814–21.[Abstract/Free Full Text]

52. Sebastian A. Dietary protein content and the diet's net acid load: opposing effects on bone health. Am J Clin Nutr. 2005;82:921–2.[Free Full Text]

53. Heaney RP. Protein and calcium: antagonists or synergists? Am J Clin Nutr. 2002;75:609–10.[Free Full Text]

54. Dawson-Hughes B. Calcium and protein in bone health. Proc Nutr Soc. 2003;62:505–9.[CrossRef][Medline]

55. Sellmeyer DE, Stone KL, Sebastian A, Cummings SR. A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of fracture in postmenopausal women. Study of Osteoporotic Fractures Research Group. Am J Clin Nutr. 2001;73:118–22.[Abstract/Free Full Text]

56. Hannan MT, Tucker KL, Dawson-Hughes B, Cupples LA, Felson DT, Kiel DP. Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000;15:2504–12.[CrossRef][Medline]

57. Ammann P, Bourrin S, Bonjour JP, Meyer JM, Rizzoli R. Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J Bone Miner Res. 2000;15:683–90.[CrossRef][Medline]

This article has been cited by other articles:

				L. Ceglia, S. S. Harris, S. A. Abrams, H. M. Rasmussen, G. E. Dallal, and B. Dawson-Hughes Potassium Bicarbonate Attenuates the Urinary Nitrogen Excretion That Accompanies an Increase in Dietary Protein and May Promote Calcium Absorption J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 645 - 653. [Abstract] [Full Text] [PDF]

				H. M Macdonald, A. J Black, L. Aucott, G. Duthie, S. Duthie, R. Sandison, A. C Hardcastle, S. A Lanham New, W. D Fraser, and D. M Reid Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial Am. J. Clinical Nutrition, August 1, 2008; 88(2): 465 - 474. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mardon, J. Articles by Coxam, V. Search for Related Content PubMed PubMed Citation Articles by Mardon, J. Articles by Coxam, V.